510(k) device
Cala kIQ
Cala Health, Inc. · External Upper Limb Tremor Stimulator (QBC, Class II) · First FDA decision Nov 22, 2022, newest Jan 16, 2025Essential tremor
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
Breakthrough-designated
Device trials
0
Naming "Cala kIQ"
MAUDE reports
3
Brand "Cala kIQ", since 2015
PubMed studies
0
Mentioning "Cala kIQ"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cala kIQ
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Cala kIQ510(k)
K243848 · Decided Jan 16, 2025 · 31 days after receipt
Device type: External Upper Limb Tremor Stimulator (QBC) · Neurology & Neurosurgery
- Cala kIQ510(k)
K242259 · Decided Nov 22, 2024 · 114 days after receipt
Device type: External Upper Limb Tremor Stimulator (QBC) · Neurology & Neurosurgery
- Cala kIQBreakthrough510(k)
K222237 · Decided Nov 22, 2022 · 119 days after receipt
Device type: External Upper Limb Tremor Stimulator (QBC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- External Upper Limb Tremor Stimulator TherapyLocal determinationIn effectL39591CGS Administrators, LLCUpdated Feb 16, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Cala kIQ", any status and sponsor, newest update first.
No registered device study names "Cala kIQ".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cala kIQ", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 3 injury, 0 death
Whole product code QBC
6 reports: 0 malfunction, 6 injury, 0 death
Newest reports for this brand
- CALA KIQInjury
3011628389-2026-00001 · Received Apr 1, 2026 · Event dated Mar 3, 2026
Device type: External Upper Limb Tremor Stimulator (QBC)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Atrial Fibrillation
- CALA KIQInjury
3011628389-2025-00001 · Received Jun 18, 2025 · Event dated May 20, 2025
Device type: External Upper Limb Tremor Stimulator (QBC)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Atrial Fibrillation
- CALA KIQInjury
3011628389-2024-00002 · Received Dec 23, 2024 · Event dated Apr 1, 2024
Device type: External Upper Limb Tremor Stimulator (QBC)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Chest Pain; Fatigue; Heart Failure/Congestive Heart Failure; Sleepiness/Drowsiness/Somnolence
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cala kIQ"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QBC.
- Cala kIQ PlusCala Health, Inc. · 510(k) 2026
- Encora X1Encora, Inc. · 510(k) 2026
- Felix NeuroAI SystemFasikl Incorporated · 510(k) 2025
- Cala TrioCala Health, Inc. · 510(k) 2021
- External upper limb tremor stimulatorCala Health, Inc. · 510(k) 2018
- Cala ONECala Health, Inc. · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.